Desvenlafaxine
NDC 0591-3659, Desvenlafaxine, tablet, extended release, from Actavis Pharma, Inc..
- Product NDC
- 0591-3659
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204065
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-3659 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DESVENLAFAXINE SUCCINATE50 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-3659-30 | 00591365930 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3659-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/617476f9-62d7-40ef-a1b1-c349d4ad706fNADAC price for package 00591365930
GET /v1/drugs/nadac/00591365930
Use it
Look up 0591-3659 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-3659 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-3659. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.